Showing results (1-10 of 325) with videos related to

Sort By:
Pageof 33
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 26, 2010
Glucocorticoid-refractory acute graft-versus-host diseaseJoseph Pidala, Claudio Anasetti
Haematologica|December 18, 2009
Can antigen-specific regulatory T cells protect against graft versus host disease and spare anti-malignancy alloresponse?Joseph Pidala, Claudio Anasetti
Haematologica|July 28, 2011
The global severity of chronic graft-versus-host disease, determined by National Institutes of Health consensus criteria, is associated with overall survival and non-relapse mortalityJoseph Pidala, Jongphil Kim, Claudio Anasetti, et al.
Current Opinion in Hematology|September 14, 2011
Have we improved in preventing and treating acute graft-versus-host disease?Lia Perez, Claudio Anasetti, Joseph Pidala
Blood|April 2, 2009
Quality of life after allogeneic hematopoietic cell transplantationJoseph Pidala, Claudio Anasetti, Heather Jim
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 23, 2009
Sirolimus as primary treatment of acute graft-versus-host disease following allogeneic hematopoietic cell transplantationJoseph Pidala, Jongphil Kim, Claudio Anasetti
British Journal of Haematology|November 19, 2009
Health-related quality of life following haematopoietic cell transplantation: patient education, evaluation and interventionJoseph Pidala, Claudio Anasetti, Heather Jim
Bone Marrow Transplantation|June 14, 2018
Hepatic veno-occlusive disease following sirolimus-based immune suppressionFarhad Khimani, George B McDonald, Howard M Shulman, et al.
Blood|September 28, 2011
Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectlyAnandharaman Veerapathran, Joseph Pidala, Francisca Beato, et al.
The Cochrane Database of Systematic Reviews|October 7, 2011
Allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia (ALL) in first complete remissionJoseph Pidala, Benjamin Djulbegovic, Claudio Anasetti, et al.
Pageof 33